Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 924 is a putative human microRNA, a member of the microRNA (miRNA) family. miRNAs are small (approximately 21–23 nucleotides), non-coding RNA molecules found in plants, animals, and some viruses that regulate gene expression at the post-transcriptional level, primarily through RNA silencing mechanisms[1][2][4]. They bind to complementary sequences in target messenger RNAs (mRNAs), leading to mRNA degradation or suppression of translation[1][2]. While there is abundant research and functional data available on major human miRNAs, such as miR-124, there does not appear to be any established biological function, disease role, or drug interaction specifically described for miR-924 in the current biomedical literature or databases. No evidence suggests it is a validated therapeutic target, biomarker, or a molecule with clinical relevance. It is included in some genomic miRNA catalogues, but detailed experimental validation and functional studies are lacking. Therefore, there is a lack of meaningful data for microRNA 924 beyond its naming as a putative miRNA, making this entry **incorrect as a therapeutic target**[1][2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 924 (miR-924).